Chief Scientific Officer Renato Skerlj sold $47K of X4 Pharmaceuticals, Inc.

Sold$46,964

$8.05Price

5,834Shares

−12%Stake

What XFOR did after the filing

Prices for XFOR after this filing aren't in yet.

Traded Wed, Sep 9. Filed Thu, Sep 10, 4:36 AM ET, before the open. Not investment advice.